About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 293 record(s)
Req # A-2020-000818
Adverse Reaction Report (AER) for Botulinum toxin. Report number: E2B_03232927.Organization: Health Canada
November 2020
Req # A-2020-000882
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: #20-103762-537, Public release of vaping results from the Canadian Tobacco and Nicotine Survey (2019) on March 5, 2020.Organization: Health Canada
November 2020
Req # A-2020-000891
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-108854-87, Memo to DM Privacy Policy Instrument for COVID-19 Initiatives.Organization: Health Canada
November 2020
Req # A-2020-000986
Adverse Reaction Report (AER) for Prevegyne® (ascorbic acid). Report number: 000563334.Organization: Health Canada
November 2020
Req # A-2016-000885
All records related to the possibility that self-care product labels may mislead the consumer, as indicated in Health Canada's consultation document entitled "Consulting Canadians on the Regulation of Self-Care Products in Canada", published on Health Canada's website on September 7, 2016.Organization: Health Canada
October 2020
Req # A-2019-001318
Adverse Reaction Reports (AERs) for Mezavant and Mesalazine. Report numbers: E2B_02173512, E2B_02176202, E2B_02196619, 000718959, E2B_02173280.Organization: Health Canada
October 2020
Req # A-2019-001246
Adverse Reaction Report (AER). Report number: E2B_02471483.Organization: Health Canada
October 2020
Req # A-2019-001921
Adverse Reaction Report (AER). Report number: E2B_02792096.Organization: Health Canada
October 2020
Req # A-2020-000146
Adverse Reaction Reports (AERs). Report numbers: E2B_02977801, E2B_02981260, E2B_02983813.Organization: Health Canada
October 2020
Req # A-2020-000379
Adverse Reaction Report (AER). Report number: 000910809.Organization: Health Canada
October 2020